Atrium Therapeutics

RNANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$153.096 M

$8.95 -6.38%

Close of 18 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

17,105,643

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#280Jyong BiotechMENS$156.6M
#281CellectisCLLS$153.8M
#282Atrium TherapeuticsRNA$153.1M
#283Spruce BiosciencesSPRB$152.5M
#284Organigram GlobalOGI$148.1M

What if Atrium Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$1,776,458

Per share 198,487× higher

Bitcoin $1.64T

$95,642.58

Per share 10,686× higher

Nvidia $5.36T

$313,154.38

Per share 34,989× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Atrium Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.